Rachel Haurwitz has been making waves in the biotech world since her days as PhD student. As a researcher in the lab of Jennifer Doudna—who later went on to win a Nobel Prize for her work on CRISPR-Cas systems—Haurwitz was there for the early days of the promising technology.
At the age of 27, she made a sharp turn away from academia into the C-suite at Caribou Biosciences,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?